For the quarter ending 2026-03-31, SEM had -$840K decrease in cash & cash equivalents over the period. -$21,038K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 63,775 | 37,742 | 44,180 | 132,611 |
| Distributions from unconsolidated subsidiaries | 14,043 | 10,155 | 11,723 | 31,092 |
| Depreciation and amortization | 37,666 | 36,205 | 34,442 | 69,656 |
| Provision for expected credit losses | 1,098 | 301 | 506 | 1,555 |
| Equity in earnings of unconsolidated subsidiaries | 12,011 | 15,399 | 12,992 | 26,130 |
| Loss on extinguishment of debt | - | 0 | 0 | - |
| (gain) loss on sale or disposal of assets | -48 | -55 | 4 | 43 |
| Stock compensation expense | 4,638 | 4,523 | 4,255 | 7,924 |
| Amortization of debt discount and issuance costs | 778 | 783 | 784 | 1,569 |
| Deferred income taxes | 6,336 | 20,105 | 17,895 | -7,348 |
| Accounts receivable | 86,370 | 38,698 | -83,144 | 89,631 |
| Other current assets | 10,563 | -7,911 | 8,060 | -562 |
| Other assets | -5,092 | 13,864 | -1,597 | -3,459 |
| Accounts payable | 21,196 | -18,626 | -3,322 | 21,094 |
| Accrued expenses | -7,866 | 33,132 | 1,159 | -39,535 |
| Net cash provided by (used in) operating activities | 37,860 | 64,325 | 175,307 | 106,835 |
| Proceeds from sale of assets | - | - | - | 39 |
| Business combinations, net of cash acquired | -31 | 7,596 | 1,601 | 0 |
| Purchases of property and equipment | 58,898 | 59,100 | 53,102 | 117,023 |
| Investment in businesses | - | 1,455 | - | - |
| Proceeds from sales and exchanges of assets and sale of business | - | 1,259 | 22,132 | - |
| Proceeds from sales of assets and business | 2,212 | - | - | - |
| Net cash used in investing activities | -56,655 | -66,892 | -32,610 | -116,984 |
| Borrowings on revolving facilities | 250,000 | 320,000 | 200,000 | 770,000 |
| Payments on revolving facilities | 225,000 | 370,000 | 300,000 | 625,000 |
| Proceeds from term loans, net of issuance costs | - | 0 | 0 | - |
| Payments on term loans | 2,625 | 2,625 | 2,625 | 5,250 |
| Payment on senior notes, including call premium | - | 0 | - | - |
| Proceeds from senior notes, net of issuance costs | - | 0 | 0 | - |
| Borrowings of other debt | 19,369 | 59,696 | 20,169 | 21,353 |
| Principal payments on other debt | 9,903 | 8,363 | 9,274 | 16,691 |
| Dividends paid to common stockholders | 7,751 | 7,751 | 7,739 | 15,945 |
| Repurchases of common stock | 0 | 542 | 1,970 | 97,565 |
| Increase (decrease) in overdrafts | 2,643 | 16,751 | -16,506 | -9,297 |
| Proceeds from issuance of non-controlling interests | 5,948 | 2,940 | 2,058 | 10,906 |
| Distributions to and purchases of non-controlling interests | 14,726 | 41,070 | 19,105 | 29,707 |
| Purchase of membership interests of concentra group holdings parent | - | 0 | - | - |
| Proceeds from concentra initial public offering | - | 0 | 0 | - |
| Cash transferred to concentra at separation | - | 0 | - | - |
| Net cash provided by financing activities | 17,955 | -30,964 | -134,992 | 2,804 |
| Net decrease in cash and cash equivalents | -840 | -33,531 | 7,705 | -7,345 |
| Cash and cash equivalents at beginning of period | 26,523 | 60,054 | 59,694 | - |
| Cash and cash equivalents at end of period | 25,683 | 26,523 | 60,054 | - |
SELECT MEDICAL HOLDINGS CORP (SEM)
SELECT MEDICAL HOLDINGS CORP (SEM)